Literature DB >> 14693848

Peroperative frozen section analysis of TTF-1 antigen expression.

S Camilleri-Broet1, M Alifano, M Morcos, E Comperat, P Magdeleinat, B Marmey, T J Molina, J-F Régnard, J Audouin.   

Abstract

BACKGROUND: The assessment of thyroid transcription factor 1 (TTF-1) expression is a useful way to investigate the origin of lung adenocarcinomas or large cell carcinomas when dealing with a solitary lung nodule in a patient with a history of extrathoracic cancer. However, if immunohistological analysis has not been performed before surgery, a peroperative frozen section may be insufficient to distinguish between a primary pulmonary tumour and a metastatic tumour. AIMS: To develop a technique for the rapid assessment of TTF-1 expression that could improve the ability of frozen section peroperative histological diagnosis to answer such questions.
METHODS: A rapid immunohistochemical technique (lasting 30 minutes) to assess the expression of TTF-1 was developed and tested.
RESULTS: Among the 45 interpretable cases, results of frozen section immunohistochemistry were similar to those found by the standard immunohistochemical technique for the expression of TTF-1.
CONCLUSIONS: This technique enables TTF-1 to be analysed peroperatively, but further prospective studies are needed to assess its usefulness in routine practice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693848      PMCID: PMC1770150          DOI: 10.1136/jcp.57.1.98

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.

Authors:  D C Chhieng; J F Cangiarella; M F Zakowski; S Goswami; J M Cohen; H T Yee
Journal:  Cancer       Date:  2001-10-25       Impact factor: 6.860

2.  Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?

Authors:  B J Robinson; T W Rice; S A Strong; L A Rybicki; E H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

3.  Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

Authors:  U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  1997-01       Impact factor: 5.209

4.  Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?

Authors:  J S Reis-Filho; C Carrilho; C Valenti; D Leitão; C A Ribeiro; S G Ribeiro; F C Schmitt
Journal:  Pathol Res Pract       Date:  2000       Impact factor: 3.250

5.  Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.

Authors:  P A Bejarano; R P Baughman; P W Biddinger; M A Miller; C Fenoglio-Preiser; B al-Kafaji; R Di Lauro; J A Whitsett
Journal:  Mod Pathol       Date:  1996-04       Impact factor: 7.842

6.  Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.

Authors:  W K Ng; Janson C Y Chow; Peter K H Ng
Journal:  Cancer       Date:  2002-02-25       Impact factor: 6.860

7.  Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1.

Authors:  R J Bohinski; P A Bejarano; G Balko; R E Warnick; J A Whitsett
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

8.  Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma.

Authors:  Joachim Pfannschmidt; Hans Hoffmann; Thomas Muley; Sabine Krysa; Christine Trainer; Hendrik Dienemann
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

  8 in total
  1 in total

1.  Diagnosis and Treatment of Metastases to the Thyroid Gland: a Meta-Analysis.

Authors:  Patrizia Straccia; Claudia Mosseri; Chiara Brunelli; Esther Diana Rossi; Celestino Pio Lombardi; Alfredo Pontecorvi; Guido Fadda
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.